United States Biological
Private Company
Funding information not available
Overview
United States Biological is a well-established, privately-held reagent supplier operating in the global life science research tools market. The company has built a strong reputation over nearly four decades for providing a vast catalog of high-purity antibodies, proteins, peptides, and biochemicals to the research community. Its business model is based on direct sales and distribution of these essential research consumables, generating revenue through a B2B and direct-to-researcher approach. USB's strategic position leverages long-term supplier relationships, in-house quality control, and a focus on niche and hard-to-find reagents to differentiate itself in a competitive market.
Technology Platform
Integrated global supply chain and quality assurance platform for sourcing, validating, and distributing life science research reagents, including antibodies, proteins, and biochemicals.
Opportunities
Risk Factors
Competitive Landscape
USB operates in the fragmented but consolidating global life science reagents market. It competes with giants like Thermo Fisher Scientific and Merck KGaA, as well as pure-play antibody specialists like Abcam (now part of Danaher) and Bio-Techne. Its competitive strategy relies on niche specialization, product quality, and customer service rather than scale alone.